Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

NCT00447330 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms
Stomach Neoplasms
Neoplasm Metastasis

Interventions

DRUG: capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin)

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]